Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Poland / NCT06959329
Starting soon Not applicable

Influence of Sensory Stimulation on Sensory Parameters and Motor Function in Children With Developmental Coordination Disorder

NCT06959329 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2025-06-01
Last updated
2025-05-13

Condition(s) studied

Developmental Coordination Disorder

Investigational drug(s) / intervention(s)

Active and passive physical therapy without intensified sensory stimulationActive and passive physical therapy with intensified sensory stimulation

Active and passive physical therapy without intensified sensory stimulation: Intervention: Passive and active therapy without high sensory stimulation Duration: 4 weeks Frequency: 3 sessions per week Session duration: 60 minutes Intervention structure: Passive therapy (30 minutes): • Stroking and rubbing techniques from classic massage applied in the area of arm forearm and hand with low force and frequency upper limb massage - 15 minutes per limb Active therapy (30 minutes): upper limb muscle strengthening exercises (without globalized vibration); difficulty level individually adjusted to meet participants' current potential, so that in the last sets/reps little manual assistance from the therapist is needed: * Supine pull-ups - 3 sets of 8 reps, \~45 seconds rest between sets * Standing pull-ups - 3 sets of 8 reps, \~45 seconds rest between sets * Standing push-ups - 3 sets of 8 reps, \~45 seconds rest between sets * Standing elbow extensions - 3 sets of 8 reps, \~45 seconds rest between sets

Active and passive physical therapy with intensified sensory stimulation: Intervention: Passive and active therapy incorporating high sensory stimulation Duration: 4 weeks Frequency: 3 sessions per week Session duration: 60 minutes Intervention structure: Passive therapy (30 minutes): stimulation of joint receptors, muscle spindles, and tactile pathways: * High-frequency soft tissue mobilisations * Localised high-amplitude vibration (30-50 Hz; Galileo Mano 30, Novotec Medical GmbH) * Deep pressure techniques - Wilbarger brushing protocol followed by joint compressions Active therapy (30 minutes): upper limb and shoulder girdle muscle strengthening exercises with globalized vibration using Redcord Stimula (30-50 Hz; Redcord AS, Norway); difficulty level individually adjusted to meet participants' current potential. Excercises the same as in the control group.

Study summary

The goal of this clinical trial is to evaluate whether intensive sensory stimulation therapy can improve upper limb motor skills and sensory function in children aged 12-16 years with severe symptoms of Developmental Coordination Disorder (DCD). The main questions it aims to answer are:

1. Will children with DCD who undergo intensive sensory stimulation therapy show greater improvement in upper limb motor function compared to those receiving standard therapy?
2. Will intensive sensory stimulation therapy lead to better sensory function outcomes, including joint position sense, resistance sense, pressure sense, temperature perception, and two-point discrimination? Researchers will compare children receiving intensive sensory stimulation therapy to those receiving standard therapy without intensive sensory stimulation to see if the targeted intervention results in superior improvements in motor and sensory function.

Eligibility

Sex
ALL
Min age
12 Years
Max age
16 Years
Healthy volunteers
No
Inclusion Criteria: * between 12-16 years of age * diagnosed severe symptoms of the developmental coordination disorder based on The Movement Assessment Battery for Children 2nd Edition (M-ABC 2), with scores ranging from 40 to 50 * typical intellectual development (i.e., children attending mainstream education) * voluntary participation and informed consent signed by parents or legal guardians Exclusion Criteria: * current or previous diagnosis of serious orthopaedic or neurological conditions (e.g. fractures, congenital deformities, cerebral palsy, etc.) * history of any surgical procedures * history of significant musculoskeletal pain or dysfunction lasting more than two weeks and requiring medical or physiotherapeutic intervention, or any such symptoms occurring within one month prior to the study * any current musculoskeletal dysfunction and/or pain * body mass index exceeding 22 kg/m³

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Daugavpils University Daugavpils Latvia
The Jerzy Kukuczka Academy of Physical Education Katowice Poland

More The Jerzy Kukuczka Academy of Physical Education in Katowice trials in Poland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06959329 on ClinicalTrials.gov ↗ ← All trials in Poland